Analytical Spectrometric Study For Determining Dapagliflozin Propanediol Monohydrate Individually Or In Presence Of Metformin Hydrochloride In Tablets Formulation
Keywords:Sodium-Glucose Cotransporter 2 (SGLT2), Derivative Spectrophotometry (1DS), Zero spectrophotometry (ZS), Metformin Hydrochloride (MET), Dapagliflozin Propanediol Monohydrate (DAPA)
First simple spectrophotometric method was developed and applied to determine Dapagliflozin Propanediol Monohydrate by Zero Spectrophotometry and First Derivative Spectrophotometric method for determining of Dapagliflozin Propanediol Monohydrate (DAPA) in the presence of Metformin Hydrochloride (MET). Zero spectrophotometric (ZS) was applied for the determination of (DAPA) at 223.5 nm. Linearity range was (2.61– 31.23) µg/mL. Regression analysis showed a good correlation coefficients R2 = 0.9989. The limit of detection (LOD) and limit of quantification (LOQ) were to be 0.569 µg/mL and 1.724 µg/mL, respectively. Derivative spectrophotometric (1DS) was applied for the determination of (DAPA) in the presence (MET). (DAPA) was determined at 233 nm (1D233). Linearity ranges were (5.21 – 41.64) µg/mL for (DAPA). Regression analysis showed a good correlation coefficients R2 = 0.9994. The limit of detection (LOD) and limit of quantification (LOQ) were to be 0.732 µg/mL and 2.218 µg/mL for (DAPA). The proposed Zero spectrophotometry method was applied to analysis individual (DAPA), and the derivative (1D233) method was applied to analysis (DAPA) individually or with (MET) combination in Syrian trademark drugs.
DrugBank: Dapagliflozin (DB06292).
Drug bank: “Dapagliflozinpropanediol”, August. 2017, https://www.drugbank.ca/salts/DBSALT001101.
Chemspider: “Dapagliflozinpropanediol” August, 2017. http://www,chemspider.com/chemical-structure.5292960.html.
Pubchem: “Dapagliflozinpropanediol”, August, 2017. https://pubchem.ncbi.nlm.nih.gov/compound/24906252.
Chitra KP, China Eswaraia M,China Eswaraiah MV. Unique UVspectrophotometric method for reckoning of dapagliflozin in bulk and pharmaceutical dosage forms. Journal of Chemical and Pharmaceutical Research. 2015; 7(9):45 – 49.
Aubry AF, Gu H, Magnier R, Morgan L, Xu X, Tirmenstein M, et al. Validated LC-MS/MS methods for the determination of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma. Bioanalysis. 2010;2(12):2001-2009.
Sanagapati M, Lakshmi DK, Reddy NG, Sreenivasa S. Development and validation of stability - Indicating RP-HPLC method for determination of dapagliflozin. J Adv Pharm Edu Res. 2014;4(3):350-353.
Madhukar A, Prince A, Vijay Kumar R, Sanjeeva Y, Jagadeeshwar K, Raghupratap D. A simple and sensitive analytical method development and validation of metformin hydrochloride by RP-HPLC. Int J Pharm PharmSci 2011;3(3):117-120.
Rajesh T, Lakshmi KS, Sharma S. Simultaneous determination of metformin and pioglitazone by reversed phase HPLC in pharmaceutical dosage forms. Int J Pharm Pharm Sci. 2009;1(2):162-166.
Akula A, Prajwala N, Sandhya M. Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and Gliclazide in bulk and combined dosage form. Int J Pharm Pharm Sci. 2013;5(4):511-517.
Bhoomaiah B, Shree JA. Development and validation of RP-HPLC method for simultaneous determination of metformin and miglitol in bulk and pharmaceutical Formulation. Int J Pharm Pharm Sci. 2014;6(6):135-141.
Prathap GM, Muthukumaran M, Krishnamoorthy B. Development and validation of simultaneously estimation of vildagliptin and metformin hydrochloride by RP-HPLC in bulk and oral dosage form. Int J Adv Pharm Gen Res. 2014;2(1):24-33.
Manasa S, Dhanalakshmi K, Reddy NG, Sreenivasa S. Method development and validation of dapagliflozin in API by RP-HPLC and UV-spectroscopy. Int J Pharm Sci Drug Res. 2014;6(3):250-
How to Cite
Copyright (c) 2020 SAAD ANTAKLI, Raghad Kabbani, and Rama Labban
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in Journal of Advances in Linguistics are licensed under a Creative Commons Attribution 4.0 International License.